Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
First-generation antihistamine-induced drowsiness and the CYP2D6 genotype
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-E-023-Monday
- By: MIURA, Jun (Hokkaido Pharmaceutical University, Pharmacotherapy, Sapporo, Japan)
- Co-author(s): Jun Miura: Pharmacotherapy, Hokkaido Pharmaceutical University, Sapporo, Japan
Hiromi Motomura: Pharmacotherapy, Hokkaido Pharmaceutical University, Sapporo, Japan
Taito Ishizaki: Pharmacotherapy, Hokkaido Pharmaceutical University, Sapporo, Japan
Kaori Yama: Pharmacotherapy, Hokkaido Pharmaceutical University, Sapporo, Japan
Shigenori Tadokoro: Health Administration Center, Muroran Institute of Technology, Muroran, Japan
Haruki Sasaki: Health Administration Center, Muroran Institute of Technology, Muroran, Japan
Maiko Machida: Pharmacotherapy, Hokkaido Pharmaceutical University, Sapporo, Japan
Nobumasa Hayase: Pharmacotherapy, Hokkaido Pharmaceutical University, Sapporo, Japan - Abstract:
Backgrounds
Marked inter-individual variation in the activity of cytochrome P450 (CYP) 2D6 has been reported. The variation is, at least in part, due to the genetic polymorphisms. Therefore, genotyping of CYP2D6 might be useful in expecting individual responses to the substrate drugs.Aims
This study aims to investigate the relation between the CYP2D.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023